- Home
- /Cholinesterase^dibucaine/Cholinesterase
Cholinesterase^dibucaine/Cholinesterase
Measures cholinesterase enzyme activity and its response to dibucaine, indicating genetic drug metabolism variants.
Why This Biomarker Matters
Identifies genetic variations affecting anesthesia metabolism. Critical finding must be disclosed before surgery to prevent serious complications from prolonged muscle paralysis.
Overview
This test measures the activity of the enzyme butyrylcholinesterase (pseudocholinesterase) and its response to the drug dibucaine. It assesses genetic variants that affect how the body metabolizes certain anesthetic drugs, particularly succinylcholine and mivacurium. A low dibucaine number or absence of response indicates a genetic variation that impairs drug metabolism, putting individuals at risk for prolonged paralysis during anesthesia. This test is critical before surgery to identify those requiring modified anesthetic protocols.
Technical Information (LOINC Codes)
Standardized laboratory codes for this biomarker
39354-6Primary72569-7Available Lab Tests
Order tests that measure this biomarker